We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065662
Recruitment Status : Active, not recruiting
First Posted : February 9, 2010
Last Update Posted : May 8, 2017
Sponsor:
Collaborators:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
National Comprehensive Cancer Network
Wyeth is now a wholly owned subsidiary of Pfizer
AstraZeneca
Information provided by (Responsible Party):
Susana M. Campos, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : September 2013
  Estimated Study Completion Date : April 2018